
News|Articles|October 2, 2002
- Pharmaceutical Technology-10-02-2002
- Volume 26
- Issue 10
Will CROs Find Opportunity in a Reinvigorated European R&D Sector? Outsourcing Outlook
Author(s)Jim Miller
The European Union is attempting to reform its current business environment in hopes of restoring its role in the lobal R&D sector.
Advertisement
Articles in this issue
over 23 years ago
FDA Launches Major Review of CGMPsover 23 years ago
Understanding Pharmaceutical Flowsover 23 years ago
Cyclodextrins as Sustained-Release CarriersNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
2
Women in STEM: Early Phase Drug Development
3
Rare Disease Treatments: Navigating the Economics of Global Innovation
4
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
5




